|
TVIS44038424
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr4 |
131434345 |
131434345 |
q28.3 |
LINC02377 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038425
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr4 |
33164153 |
33164153 |
p15.1 |
ENSG00000287968 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038426
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr4 |
92989079 |
92989079 |
q22.2 |
GRID2 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038427
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr4 |
51287291 |
51287291 |
q11 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038428
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr4 |
92840344 |
92840344 |
q22.2 |
GRID2 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038429
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr4 |
108164380 |
108164380 |
q25 |
LEF1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038430
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr4 |
49709328 |
49709328 |
p11 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038431
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr4 |
143791354 |
143791354 |
q31.21 |
GUSBP5 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038432
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr4 |
70838351 |
70838351 |
q13.3 |
GRSF1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44038433
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr4 |
70326194 |
70326194 |
q13.3 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |